ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NVCT Nuvectis Pharma Inc

6.72
0.00 (0.00%)
Pre Market
Last Updated: 07:00:03
Delayed by 15 minutes

Nuvectis Pharma Financial Summary

The current NVCT market cap is 119.41M. The company's latest EPS is USD -1.2528 and P/E is -5.36.

Quarter End
USD ($)USD ($)USD ($)USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -10k-12.89M-19.23M-22.9M
Net Income -10k-12.89M-19.09M-22.26M
Quarter End
USD ($)USD ($)USD ($)USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Assets 06.66M20.41M19.19M
Total Liabilities 10k2.42M6.19M6.98M
Total Equity -10k-11.01M14.22M12.2M
Quarter End
USD ($)USD ($)USD ($)USD ($)
Operating
Investing
Financing
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Operating N/A -9.5M-13.56M-15.95M
Investing N/A N/A N/A N/A
Financing N/A 15.25M27.81M15.09M
Market Cap 119.41M
Price to Earnings Ratio -5.36
Price to Sales Ratio 0
Price to Cash Ratio 6.24
Price to Book Ratio 9.79
Dividend Yield -

Share Statistics

Shares Outstanding 17.77M
Average Volume (1 week) 76.19k
Average Volume (1 Month) 58.11k
52 Week Change -54.16%
52 Week High 18.65
52 Week Low 6.20
Spread (Intraday) 3.79 (38.52%)

Company Info

Company Name Nuvectis Pharma Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.nuvectis.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock